Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Preparation of Lyophilized DNA and RNA Formulations

Posted on By

SOP for Preparation of Lyophilized DNA and RNA Formulations

Standard Operating Procedure for Preparation of Lyophilized DNA and RNA Formulations

1) Purpose

This SOP outlines the procedure for preparing lyophilized DNA and RNA formulations to ensure the stability and preservation of genetic material during storage and transportation.

2) Scope

This SOP applies to all personnel involved in the preparation, handling, and testing of lyophilized DNA and RNA formulations, including formulation scientists, production operators, and QA personnel.

3) Responsibilities

  • Formulation Scientists: Responsible for selecting appropriate stabilizers and excipients to protect nucleic acids during lyophilization.
  • Operators: Responsible for the preparation and lyophilization of DNA/RNA formulations as outlined in the Batch Manufacturing Record (BMR).
  • QA: Responsible for ensuring proper documentation and verification of lyophilization parameters.
See also  Lyophilized Products : SOP for Reconstitution Testing of Lyophilized Products

4) Procedure

4.1 Formulation Development

4.1.1 Criteria for DNA/RNA Stability

  • 4.1.1.1 The formulation should ensure the stability of DNA/RNA during freeze-drying and long-term storage.
  • 4.1.1.2 Stabilizers such as trehalose, sucrose, or other cryoprotectants are commonly used to prevent degradation.

4.2 Preparation and Lyophilization

4.2.1 Solution Preparation

  • 4.2.1.1 Weigh the required nucleic acids and stabilizers as specified in the BMR.
  • 4.2.1.2 Dissolve the DNA or RNA in a suitable buffer, such as Tris-EDTA, and stir until fully dissolved.

4.2.2 Sterile Filtration and Filling

  • 4.2.2.1 Filter the solution through a sterile 0.22-micron filter to ensure sterility.
  • 4.2.2.2 Aseptically fill the vials and freeze at -80°C before lyophilization.
See also  SOP for Monitoring pH in Lyophilized Formulations

4.3 Lyophilization and Testing

  • 4.3.1 Transfer the vials to the lyophilizer and run the lyophilization cycle as specified in the BMR.
  • 4.3.2 After lyophilization, test the reconstituted product for DNA/RNA integrity and functional activity using appropriate assays.

4.4 Documentation

Record all steps in the DNA/RNA Lyophilization Logbook, including formulation preparation, filtration, and lyophilization parameters, and ensure QA verification.

5) Abbreviations

  • BMR: Batch Manufacturing Record
  • Tris-EDTA: Tris(hydroxymethyl)aminomethane – Ethylenediaminetetraacetic acid

6) Documents

  • DNA/RNA Lyophilization Logbook

7) References

  • Scientific literature on DNA and RNA stabilization techniques during lyophilization

8) SOP Version

Version 1.0

Annexure

DNA/RNA Lyophilization Logbook Template

Date DNA/RNA Type Batch No. Stabilizer Used Integrity Testing Operator Initials QA Verification
DD/MM/YYYY DNA/RNA Type Batch Number Stabilizer Name Pass/Fail Operator Name QA Initials
             


See also  SOP for Weighing and Dispensing of Raw Materials for Lyophilization
Lyophilized Products Tags:Aseptic lyophilization process SOP, FDA guidelines for lyophilized products, Freeze-drying cycle development SOP, Lyophilized product SOP, Lyophilizer calibration SOP, Moisture content testing in lyophilized products, Pharmaceutical freeze-drying SOP, Quality control SOP for lyophilized drugs, SOP for cryoprotectants in lyophilized formulations, SOP for freeze-dried formulation optimization, SOP for handling lyophilized products, SOP for lyophilization of injectable drugs, SOP for lyophilization process in pharmaceuticals, SOP for lyophilization process validation, SOP for lyophilized antibiotics production, SOP for lyophilized product packaging, SOP for lyophilized product storage, SOP for lyophilized product vial filling, SOP for lyophilized vaccine production, SOP for lyophilizer equipment maintenance, SOP for pharmaceutical freeze-drying validation, SOP for primary drying in lyophilization, SOP for reconstitution of lyophilized drugs, SOP for secondary drying in lyophilization, SOP for stability testing of lyophilized products

Post navigation

Previous Post: Nanoparticle Formulation : SOP for Incorporation of Targeting Ligands in Nanoparticle Formulations
Next Post: SOP for Preparation of Immunoliposomes for Targeted Drug Delivery

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version